Dual specificity CD19/CD22 CAR-T cell immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dual specificity CD19/CD22 CAR-T cell immunotherapy, covering 2025-12-15 to 2025-12-15. Get the full timeline:
Most recent: Clinical Trial Update: A Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Leukemia [Phase 1]